Endothelial dysfunction, often demonstrated by the loss of the endothelial cell's ability to cause vasodilation in response to appropriate stimuli, is one of the earliest events in the development of atherosclerosis. This has led to intense investigation of the factors affecting both the production and the degradation of NO, the endothelium-derived relaxing factor and a primary mediator of endothelial function. Reactive oxygen species (ROS), particularly superoxide anion, are well known to inhibit NO, and therefore the mechanisms by which endothelium regulates production of ROS are also of high interest. In this issue of The American Journal of Pathology, Zhang et al 1 demonstrate regulation of such events by a mitochondria-specific thioredoxin, which reduces oxidative stress and increases NO bioavailability, thus preserving vascular endothelial cell function and preventing atherosclerosis development.
Regulation of Reactive Oxygen Species (ROS) and Reactive Nitrogen Species in Endothelial FunctionIt has long been described that superoxide rapidly reacts with NO to inactivate it-in fact, this was a major clue to the original identification of endothelial-derived relaxation factor as NO.2 Superoxide reacts directly with NO with high affinity to form the reactive nitrogen species peroxynitrate. In addition to inactivating NO, ROS have a host of potentially deleterious effects, and antioxidants are widely touted as having some potential for heart disease prevention. However, initial results from clinical trials of antioxidants have been disappointing, suggesting that we have insufficient understanding of the specific roles of ROS and antioxidants to design effective therapies.Although oxidative stress is broadly considered to be pathogenic, ROS are not always unwanted by-products. Cells actively regulate ROS with both antioxidant and pro-oxidant enzyme systems, and in fact, production of superoxide by endothelial cells is an essential part of the signaling that leads to vasoconstriction. The superoxideproducing NADPH oxidases were once thought to function solely as cell-killing engines in phagocytes, but they are also present in endothelial cells.3 Mice lacking the NADPH oxidase subunit p47 no longer generate endothelial superoxide in response to angiotensin II and have a blunted hypertensive response to angiotensin in vivo. 4 Although NADP(H) oxidases have been established as an important pathway for ROS generation in response to angiotensin, the p47-null mouse does not show any differences in resting blood pressure or in progression of atherosclerosis on the background of the highly atherogenic ApoE-deficient mouse.5 Perhaps dysregulation of other pathways is important for the development of dysfunction.
Thioredoxins: Beyond Scavenging?Thioredoxin proteins are classically defined by their ability to reduce disulfides (an SOS bond) to dithiols (two OSH groups), and in the process the thioredoxins are oxidized from a dithiol to a disulfide. The thioredoxin disulfide is then cycled back to its active form by the en...